Hover a dot or row, or tab through the dots · bars scaled to the largest round ($1.2M)
Form D offerings
One line per offering, amendments folded in, newest first
Form D offerings
File
First filed
Latest
Sought
Sold
Investors
Exemptions
021-558910
First filed2025-09-26
Latest2025-09-26
Sought$10.4M
Sold$0
Investors0
Exemptions506(c)
021-548068
First filed2025-06-04
Latest2025-06-04
Sought$3.5M
Sold$250K
Investors1
Exemptions506(c)
021-537978
First filed2025-02-11
Latest2025-02-12
Sought$2.3M
Sold$428K
Investors6
Exemptions506(c)
021-525093
First filed2024-09-26
Latest2024-09-30
Sought$2.3M
Sold$838K
Investors2
Exemptions506(b)
021-513840
First filed2024-05-21
Latest2024-05-21
Sought$2.3M
Sold$250K
Investors2
Exemptions506(b)
021-506999
First filed2024-03-07
Latest2024-03-07
Sought$1.2M
Sold$100K
Investors5
Exemptions506(c)
021-481898
First filed2023-05-17
Latest2023-05-17
Sought$3.5M
Sold$120K
Investors5
Exemptions506(c)
021-464231
First filed2022-11-08
Latest2022-11-08
Sought$3.5M
Sold$100K
Investors1
Exemptions506(c)
021-419265
First filed2021-10-29
Latest2021-10-29
Sought$3.5M
Sold$1.2M
Investors4
Exemptions506(c)
021-397021
First filed2021-04-23
Latest2021-04-23
Sought$3.5M
Sold$225K
Investors2
Exemptions506(c)
021-369458
First filed2020-06-23
Latest2020-06-23
Sought$3M
Sold$600K
Investors3
Exemptions506(c)
021-346237
First filed2019-08-09
Latest2019-08-12
Sought$3M
Sold$467K
Investors15
Exemptions506(c)
021-309340
First filed2018-04-04
Latest2018-04-04
SoughtIndefinite
Sold$0
Investors433
Exemptions506(b)
021-305819
First filed2018-02-16
Latest2018-02-16
Sought$3.5M
Sold$229K
Investors9
Exemptions506(c)
021-285979
First filed2017-05-03
Latest2017-05-03
Sought$3.5M
Sold$12K
Investors1
Exemptions506(c)
021-273525
First filed2016-10-31
Latest2016-10-31
Sought$1.4M
Sold$47K
Investors7
Exemptions506(c)
021-249849
First filed2015-10-21
Latest2015-10-21
Sought$2.8M
Sold$55.5K
Investors5
Exemptions506(c)
021-225568
First filed2014-10-01
Latest2014-10-01
Sought$5.5M
Sold$50K
Investors1
Exemptions506(c)
Who backs MED-X, Inc., inferred from co-filings, and every Form D as filedSee plans
People
Named in Item 3 of its latest Form D, filed 2025-09-26
Related persons
Name
Relationship
MATTHEW MILLS
RelationshipExecutive Officer, Director
RONALD TCHORZEWSKI
RelationshipExecutive Officer, Director
JENNIFER MILLS
RelationshipExecutive Officer, Director
MICHAEL KUNTZ
RelationshipDirector
FRED DASHIELL, JR.
RelationshipDirector
ALLAN KURTZ
RelationshipDirector
MARY KAY WILSON
RelationshipDirector
Sales compensation
Named in Item 12 of its Form D filings
Sales compensation recipients
Recipient
CRD
Broker-dealer
Offerings
MARCO POLO SECURITIES, INC.
CRD46561
Broker-dealer—
Offerings1
Facts
As its latest Form D states them
Industry
Other
State
California (CA)
Exemptions
Rule 506(c); Rule 506(b)
First filed
2014-10-01
Latest filing
2025-09-26
Minimum investment
$90K
Who backs MED-X, Inc.
Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.
Inferred investors — the funds and firms behind it, from co-filings and shared people
Every Form D and amendment as filed, with what each one stated
Its rounds in sequence: the gap between them and whether they grew
Everyone its filings name, linked to their other companies, with its addresses and phone numbers
Part of the Venture plan — $140/mo at launch pricing ($350 list)